Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Acquisitions (2018 - 2022)

Collegium Pharmaceutical (COLL) has 2 years of Acquisitions data on record, last reported at $572.1 million in Q1 2022.

  • For Q1 2022, Acquisitions changed N/A year-over-year to $572.1 million; the TTM value through Dec 2022 reached $572.1 million, changed N/A, while the annual FY2024 figure was $267.5 million, N/A changed from the prior year.
  • Acquisitions reached $572.1 million in Q1 2022 per COLL's latest filing, up from $116000.0 in the prior quarter.
  • Across five years, Acquisitions topped out at $572.1 million in Q1 2022 and bottomed at $116000.0 in Q2 2018.